Abstract

The European Medicines Agency (EMA) has been forced to put its move to greater transparency on hold in the light of legal advice, after it was taken to court by...

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title
Journal
Date
Author
Drug company drops case after EMA agrees to redactions in some documents to be published
C Dyer
BMJ (Clinical research ed.) | VOL. 348
C DyerC Dyer
07 Apr 2014
More transparency for clinical trial data: The decision by the European Medicines Agency to make clinical trial reports publicly available could provide a boon for biomedical research.
Philip Hunter
EMBO Reports | VOL. 16
Philip HunterPhilip Hunter
04 Dec 2014
AbbVie considers harms to be commercially confidential information: sign a petition
P C Gotzsche
BMJ (Clinical research ed.) | VOL. 347
P C GotzscheP C Gotzsche
23 Dec 2013
US Pharma's Financialized Business Model
William Lazonick ... Oner Tulum
SSRN | VOL. -
William Lazonick, et. al.William Lazonick ... Oner Tulum
13 Sep 2017
View more papers

More From: BMJ (Clinical research ed.)

Paper Title
Journal
Date
Author
Four year medical degrees in the UK
Gabrielle M Finn ... Paul A Tiffin
BMJ (Clinical research ed.) | VOL. 386
Gabrielle M Finn, et. al.Gabrielle M Finn ... Paul A Tiffin
01 Aug 2024
Scarlett McNally: We can all do better to encourage diversity to benefit staff and patients
Scarlett Mcnally
BMJ (Clinical research ed.) | VOL. 386
Scarlett McnallyScarlett Mcnally
01 Aug 2024
V Craig Jordan: pharmacologist and father of tamoxifen
Janet Fricker
BMJ (Clinical research ed.) | VOL. 386
Janet FrickerJanet Fricker
01 Aug 2024
Covid-19: “Substantial psychiatric burden” is still seen three years after infection, researchers find
Jacqui Wise
BMJ (Clinical research ed.) | VOL. 386
Jacqui WiseJacqui Wise
01 Aug 2024
View more papers